Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER
MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
Market for our Common Stock
Our common stock is quoted on the NYSE American under the
symbol “PLAG”.
Approximate Number of Holders of Our Common Stock
As of December 31, 2023, there were 322 stockholders
of record of our common stock. This does not include the holders whose shares are held in a depository trust in “street” name.
Dividend
We have not declared or paid cash dividends other
than the payment of a dividend in April 2007 in connection with our reverse merger. Any future decisions regarding dividends will be made
by our Board of Directors. We currently intend to retain and use any future earnings for the development and expansion of our business
and do not anticipate paying any cash dividends in the foreseeable future.
Issuances of Unregistered Securities
On May 9, 2019, we and Shanghai Xunyang entered
into a share exchange agreement with Xianning Bozhuang and each of the original shareholders of Xianning Bozhuang. Such transaction closed
on May 14, 2019. Pursuant to the share exchange agreement, we issued an aggregate of 1,080,000 shares of common stock of the Company to
the Sellers in exchange for the transfer of all of the equity interest of Xianning Bozhuang to Shanghai Xunyang.
23
On June 17, 2019, the Company entered into a securities
purchase agreement, pursuant to which five individuals residing in the PRC agreed to purchase an aggregate of 1,300,000 shares of the
Company’s common stock, par value $0.001 per share, for an aggregate purchase price of $5,460,000, representing a purchase price
of $4.20 per share. The transaction closed on June 19, 2019.
On January 26, 2021, the Company entered into a
securities purchase agreement, pursuant to which three individuals residing in the PRC agreed to purchase an aggregate of 2,700,000 shares
of the Company’s common stock, par value $0.001 per share, for an aggregate purchase price of $6,750,000, representing a purchase
price of $2.50 per share. The transaction closed on January 29, 2021.
On March 9, 2021, the Company entered into a share
exchange agreement with Jilin Chuangyuan and each of the original shareholders of Jilin Chuangyuan. Pursuant to the share exchange agreement,
we issued an aggregate of 3,300,000 shares of common stock of the Company to the Sellers in exchange for the transfer of 75% of the equity
interest of Jilin Chuangyuan.
On April 24, 2021, the Company entered into a securities
purchase agreement, pursuant to which three individuals residing in the PRC agreed to purchase an aggregate of 4,000,000 shares of the
Company’s common stock, par value $0.001 per share, for an aggregate purchase price of $7,600,000, representing a purchase price
of $1.90 per share. The transaction closed on May 20, 2021.
On July 15, 2021, the Company entered into a share
exchange agreement with Anhui Ansheng and each of the original shareholders of Anhui Ansheng. Pursuant to the share exchange agreement,
we issued an aggregate of 4,800,000 shares of common stock of the Company to the Sellers in exchange for the transfer of 66% of the equity
interest of Anhui Ansheng.
On December 9, 2021, the Company entered into a
share exchange agreement with Shandong Yunchu and each of the original shareholders of Shandong Yunchu. Pursuant to the share exchange
agreement, we issued an aggregate of 5,900,000 shares of common stock of the Company to the Sellers in exchange for the transfer of all
of the equity interest of Shandong Yunchu.
On January 13, 2022, the Company entered into a
securities purchase agreement, pursuant to which three individuals residing in the PRC agreed to purchase an aggregate of 7,000,000 shares
of the Company’s common stock for an aggregate purchase price of $7,000,000, representing a purchase price of $1.00 per share. The
transaction closed on January 14, 2022.
On April 8, 2022, the Company enterted into a share
exchange agreement with Allinyson and each of the orginial shareholders of Allinyson. including its wholly-owned subsidiary Baokuan Technology
(Hongkong) Limited.Pursuant to the share exchange agreement, we issued an aggregate of 7,500,000 shares of common stock of the Company
to the Sellers in exchange for the transfer of all of the equity interest of Allinyson.
On May 19, 2022, the Company entered into a Securities
Purchase Agreement with two investors residing in the People’s Republic of China, pursuant to which the purchasers agreed to invest
an aggregate of $4,100,000 in the Company in exchange for an aggregate of 10,000,000 shares of the Company’s common stock, representing
a purchase price of $0.41 per share. The transaction closed on May 27, 2022.
On July 15, 2022, the Company enerted into a share
exchange agreement with Xiangtian Energy and the the shareholder of Xiantian Energy. Pursuant to the Share Exchange Agreement, in exchange
for the acquisition of the 30% equity interest of Xiangtian Energy, the Company issued an aggregate of 12,000,000 shares of common stock,
par value $0.001 per share, of the Company to the Seller.
Securities Authorized for Issuance under Equity Compensation
Plans
We did not issue any shares under our equity compensation
plan in the fiscal year of 2023.
ITEM 6. RESERVED
Not applicable.
24
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.